Platinum’s founder, Kerr Neilson recently expressed his enthusiasm for the biotech sector. Dr Bianca Ogden, specialist in the field and portfolio manager at Platinum, shares her own excitement for this rapidly growing sector. From gene sequencing, to new drug modalities and molecular profiling – biotechs are playing a leading role in transforming our lives.
Disclaimer
DISCLAIMER: The above information is commentary only (i.e. our general thoughts). It is not intended to be, nor should it be construed as, investment advice. To the extent permitted by law, no liability is accepted for any loss or damage as a result of any reliance on this information. Before making any investment decision you need to consider (with your financial adviser) your particular investment needs, objectives and circumstances.
From the journal
Video
watch | 9 Apr 2024
Video – The lure of large numbers
The Platinum team look at some high-quality companies growing their businesses in huge markets
Article
3 min read | 12 Mar 2024
Fear of Running Out
Uranium buyers are worried about supply. That could be good news for investors.
Webinar
watch | 7 Mar 2024
2024 Q1 Adviser Update Webinar
In this recently recorded webinar, Co-Chief Investment Officer, Andrew Clifford, provided key insigh...
Article
5 min read | 27 Feb 2024
Toyota: How the hybrid engine regeared the investment case
Last year 9 million people bought a Toyota. Here’s why Platinum bought more of the company.
Subscribe to Platinum
Receive our expert investment insights and market updates.
Journal Articles
Read market leading insights.
Market Updates
Get market updates from our analysts
Quarterly Reports
Receive quarterly investment reports